A carregar...
Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
BACKGROUND: Tacrolimus is the key immunosuppressive drug for liver transplantation. Once-daily prolonged-release tacrolimus (TAC-PR) exhibits good drug adherence but has difficulty controlling the trough level in the early phase of liver transplantation. The aim of this study was to compare the feas...
Na minha lista:
| Publicado no: | Transplant Direct |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5585423/ https://ncbi.nlm.nih.gov/pubmed/28894794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000722 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|